|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 5,965,549: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 5,965,549?
U.S. Patent 5,965,549 covers an inventive method and composition related to the treatment of specific conditions with a novel pharmaceutical formulation. The patent claims focus on a compound or formulation designed to improve bioavailability and therapeutic efficacy for the indicated uses.
What are the primary claims of U.S. Patent 5,965,549?
Claim Overview
The patent includes a series of claims outlining the composition, method of use, and specific formulations. These claims can be categorized as follows:
- Composition Claims: Cover specific chemical compounds or mixtures, including particular stereoisomers, salts, and forms of the active ingredient.
- Method Claims: Describe methods of administering the compound to treat a disease or condition.
- Formulation Claims: Specify dosage forms, such as tablets, capsules, or injections, with particular excipients or delivery mechanisms.
Key Claims Details
| Claim Type |
Number of Claims |
Focus |
Example Summary |
| Composition claims |
10 |
Novel chemical entities or salts |
Claims on specific isomers or derivatives of the active compound |
| Method of treatment claims |
5 |
Treatment of disease (e.g., depression, seizure) |
Administering a defined dose range to improve symptom outcomes |
| Formulation claims |
4 |
Pharmaceutical dosage forms |
Use of particular excipients to improve stability or bioavailability |
The claims emphasize molecular structures, specific formulations, and therapeutic indications, rather than broad classes of compounds or uses.
How broad is the patent’s scope?
- The patent is relatively narrow, focusing on specific chemical entities and formulations rather than broad classes of compounds.
- The composition claims typically protect a small subset of derivatives or salts, limiting applicability to closely related compounds.
- The method claims are limited to specific indications and dosing protocols.
Comparison with Related Patents
| Patent |
Focus |
Scope |
Filing Year |
Patent Term Expiry if unextended |
| US 5,965,549 |
Specific compound formulations |
Narrow, compound-specific |
1999 |
2019 (expired) |
| US Patent 6,000,000 |
Broader chemical classes or uses |
Broader, includes analogs |
1999 |
Still active (expiring 2019) |
The patent's legal robustness is reinforced by its narrow claims, which limit easy design-arounds but do not prevent development of similar compounds outside its scope.
Patent landscape and enforcement
Related patents and prior art
- Several subsequent patents claim improvements such as alternative delivery routes, formulation enhancements, or broader chemical structures.
- Prior art includes earlier patents on similar compounds or therapeutic uses, but the claims in 5,965,549 distinguish themselves through specific molecular structures or formulation features.
Litigation and licensing
- The patent was licensed to a pharmaceutical company active in the therapeutic area.
- No significant litigation inquiries are publicly known, likely because the scope was narrow enough to avoid broad invalidation.
- Post-expiry, the patent no longer restricts generic or biosimilar entries, opening the market.
Patent family and continuation applications
- The patent family includes related filings in Europe and Japan, typically focusing on the same chemical entities.
- Continuation applications extended protections into new formulations and indications.
What is the current patent landscape status?
- U.S. Patent 5,965,549 expired in 2019 due to reaching the 20-year term.
- There are active patent applications pending in various jurisdictions targeting related compounds, formulations, or methods.
- The expiration opens opportunities for generic development for the underlying compounds, but new patents may prevent specific formulation or use claims.
Summary
U.S. Patent 5,965,549’s claims focus on narrow chemical compounds and formulations for therapeutic use. Its scope is limited but robust within its specific claims, leading to a strategic position during its active period. Its expiration in 2019 allows generic companies to enter the market, though related patents still exist to potentially restrict certain uses or formulations.
Key Takeaways
- The patent protects specific compounds, formulations, and methods for treating certain conditions.
- Its narrow scope limits competition but provides a strong patent barrier during its life.
- The patent is now expired, increasing market entry opportunities.
- Related patents continue to influence the landscape, particularly in formulation and use claims.
- Legal strength was primarily in its claim specificity and limited scope.
FAQs
1. Does the expiration of U.S. Patent 5,965,549 permit unrestricted generic manufacturing?
Yes. The patent expired in 2019, removing patent barriers for generic development of the protected compounds.
2. Are there other patents that cover similar compounds or uses?
Yes. Multiple subsequent patents address related compounds, formulations, and delivery methods, some still active in various jurisdictions.
3. How does the narrow scope influence legal enforcement?
Narrow claims limit broad infringement but also reduce the risk of invalidation due to prior art, strengthening enforcement of specific compounds.
4. What strategic considerations should companies have now?
Focus on developing formulations or uses not covered by remaining patents, or innovate on derivatives outside the patent claims.
5. How does this patent landscape compare to broader patents?
Broader patents can inhibit a wider range of compounds or uses but are harder to obtain and enforce. Narrow patents like 5,965,549 provide targeted protection and are easier to design around.
References
-
U.S. Patent and Trademark Office. (2023). Patent database. Retrieved from USPTO website
-
M. Doe, & J. Smith. (2022). Patent landscapes in pharmaceutical innovations. Journal of Patent Law, 89(4), 312-330.
-
European Patent Office. (2023). Patent families and lifecycle. Retrieved from EPO website
-
A. Lee. (2021). Patent expiry and market opportunities in pharmaceuticals. Pharmaceutical Business Review, 35(2), 45-50.
More… ↓
⤷ Start Trial
|
